These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 16531710)
1. [Gastric cancer]. Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Gotouda N Gan To Kagaku Ryoho; 2006 Mar; 33(3):313-7. PubMed ID: 16531710 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer]. Kitamura M; Arai K; Iwasaki Y Gan To Kagaku Ryoho; 1997 Aug; 24(10):1221-9. PubMed ID: 9279340 [TBL] [Abstract][Full Text] [Related]
3. [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer]. Saka M; Sasako M; Katai H; Sano T Gan To Kagaku Ryoho; 2000 Nov; 27(13):2033-42. PubMed ID: 11103234 [TBL] [Abstract][Full Text] [Related]
4. [Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer]. Sasako M; Sano T; Katai H; Okajima K; Maruyama K Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():384-94. PubMed ID: 7986119 [TBL] [Abstract][Full Text] [Related]
5. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States. Ohtsu A; Sasako M Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444 [TBL] [Abstract][Full Text] [Related]
6. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany]. Bösing NM; Heise JW; Röher HD Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314 [TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial]. Sasako M; Saka M; Fukagawa T; Katai H; Sano T Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():110-6. PubMed ID: 16897984 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives. Sakamoto J; Morita S; Kodera Y; Rahman M; Nakao A Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511 [TBL] [Abstract][Full Text] [Related]
9. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy. Yu W Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532 [TBL] [Abstract][Full Text] [Related]
10. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757 [TBL] [Abstract][Full Text] [Related]
11. A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial. Tsuburaya A; Sakamoto J; Morita S; Kodera Y; Kobayashi M; Miyashita Y; Macdonald JS Jpn J Clin Oncol; 2005 Nov; 35(11):672-5. PubMed ID: 16275676 [TBL] [Abstract][Full Text] [Related]
12. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study. Nio Y; Koike M; Omori H; Hashimoto K; Itakura M; Yano S; Higami T; Maruyama R Anticancer Res; 2004; 24(3b):1879-87. PubMed ID: 15274369 [TBL] [Abstract][Full Text] [Related]
13. [Randomized controlled trial of postoperative adjuvant chemotherapy with bestatin for gastric cancer]. Tanaka T; Oka T; Hashimoto I Gan To Kagaku Ryoho; 1985 Jan; 12(1):125-33. PubMed ID: 3917653 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy in gastric cancer. Lim L; Michael M; Mann GB; Leong T J Clin Oncol; 2005 Sep; 23(25):6220-32. PubMed ID: 16135489 [TBL] [Abstract][Full Text] [Related]
15. [Comparative clinical studies for head and neck cancer in Japan]. Fujii M Gan To Kagaku Ryoho; 2002 Sep; 29(9):1502-8. PubMed ID: 12355935 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of intensive adjuvant chemotherapy in gastric cancer using life expectancy compared with log-rank test as a measure of survival benefit. Nishikawa T; Maetani S Ann Surg Oncol; 2007 Feb; 14(2):348-54. PubMed ID: 17091331 [TBL] [Abstract][Full Text] [Related]
17. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer. Briasoulis E; Liakakos T; Dova L; Fatouros M; Tsekeris P; Roukos DH; Kappas AM Expert Rev Anticancer Ther; 2006 Jun; 6(6):931-9. PubMed ID: 16761937 [TBL] [Abstract][Full Text] [Related]
18. [Progress in postoperative adjuvant chemotherapy in gastric cancer]. Nakajima T; Ohta K; Ohyama S; Yamaguchi T Gan To Kagaku Ryoho; 2002 Dec; 29(13):2481-7. PubMed ID: 12506470 [TBL] [Abstract][Full Text] [Related]
19. The gastric cancer treatment controversy. van de Velde CJ; Peeters KC J Clin Oncol; 2003 Jun; 21(12):2234-6. PubMed ID: 12805321 [No Abstract] [Full Text] [Related]